GNCA (GNCA) Stock Price, News & Analysis

Name: GNCA (GNCA) Financial Data & Stock Overview
Creator: Stock Titan
License: https://www.stocktitan.net/terms-of-use

GNCA OTC

Company Description

GNCA (OTC: GNCA) is classified in the biological product (except diagnostic) manufacturing industry within the Manufacturing sector.

This page collects what Stock Titan holds for GNCA, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

Latest News

View All

May 24, 2022

-72.69%

Genocea Announces Wind Down of Operations and Delisting From NASDAQ

April 28, 2022

-30.55%

Genocea Initiates Restructuring and Announces Plan to Explore Strategic Alternatives

April 8, 2022

-69.23%

Genocea Presents Encouraging Initial Data from GEN-011 Phase 1/2a Trial at AACR 2022

clinical trial

April 4, 2022

+7.81%

Genocea Biosciences to Host Investor Webinar

conferences

March 14, 2022

-1.77%

Genocea to Present at the 32nd Annual Oppenheimer Healthcare Conference

conferences

March 10, 2022

-1.68%

Genocea Provides Fourth Quarter 2021 Corporate Update

earnings

GNCA has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include clinical trial, conferences, earnings, management. View all GNCA news →

SEC Filings

View All

No SEC filings available for GNCA.

Financial Highlights

—

Revenue (latest FY)

—

Net Income (latest FY)

—

Diluted EPS (latest FY)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

GNCA Company Profile & Sector Positioning

GNCA (GNCA) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.